Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trial.
Biegus J, Mebazaa A, Metra M, Pagnesi M, Chioncel O, Davison B, Filippatos G, Tycińska A, Novosadova M, Gulati G, Barros M, Diaz ML, Guardia C, Zymliński R, Gajewski P, Ponikowski P, Simmons P, Simonson S, Cotter G.
Biegus J, et al. Among authors: simmons p.
ESC Heart Fail. 2024 Oct 7. doi: 10.1002/ehf2.15102. Online ahead of print.
ESC Heart Fail. 2024.
PMID: 39375885
Free article.